vic-1911
vitrac therap
['nsclc', 'vic-1911', 'sclc']
dr. barbara burtness and dr. sarah goldberg highlight an investigator initiated phase i #clinicaltrial studying the aurora kinase inhibitor vic-1911 as treatment for kras-mutant #nsclc available . #asco23 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.